semaglutide and lymphedema St Louis Treatments Symptoms Frontiers | Glucagon-like peptide-1 receptor

Compounded versions, when prescribed, are not FDA-approved and have not been evaluated for safety, efficacy, or quality by the FDA

Aim for steady weight loss guided by your provider

Users may experience weight loss of 1520 % of body weight, which typically equates to around 35 pounds per week, depending on individual response

Approved by the FDA in 2011 for RLS and 2012 for PHN, this medication has become a first-line treatment option as clinical guidelines have evolved significantly

Mol Pharmacol (2005) 68(3):84754

Our published research found that members taking semaglutide alongside this support achieved an average of 19.1% weight loss at 12 months, with 77.7% reaching at least 10% weight loss